GLP-1 Medication Guide

The patient notebook

A little clarity, one question at a time.

Open the source shelf ↗

Take it one page at a time

A note for your
next question.

Choose a starting point. Each note ends with the primary sources behind it.

01
Choosing care

Best GLP-1 providers: a patient’s starting notebook

Ten services and access routes, with the questions to ask before you become a patient.

02
Understanding the medicine

Read your medication label without guessing

A practical way to organize the name, instructions and pharmacy contact before asking for clarification.

03
Before the appointment

A calmer way to prepare for your first GLP-1 visit

Bring your history, your priorities and a few concrete questions. You do not need a finished treatment plan.

04
After the appointment

Keep your GLP-1 care connected between visits

A refill, a billing renewal and a clinical review can happen on different schedules. Put each one in its own place.

05
Food & support

Make room for nutrition questions in your care notes

Write down what eating is actually like, then ask which qualified professional can help.

06
Care logistics

Keep the test, the bill and the result together

A laboratory order is easier to follow when you know its purpose, cost and review plan.

07
Before a procedure

Tell every procedure team about your GLP-1 medicine

An upcoming operation or sedated procedure needs a coordinated medication conversation.

08
Scientific article

Semaglutide Injection in ESSENCE: What the MASH Biopsy Results Establish

The 72-week ESSENCE analysis found improvements in liver inflammation and scarring. Understanding the result requires separating biopsy outcomes, accelerated approval, long-term clinical benefits, and the exact medication studied.

09
Scientific article

ATTAIN-1’s Oral Orforglipron Results: Weight Loss, Tablet Identity, and the Foundayo Label

The 72-week trial established a weight-loss benefit over placebo. Understanding its estimates requires separating investigational tablet doses from marketed Foundayo strengths—and separating oral-drug evidence from injectable comparisons.